IONTAS has been granted approval for Partners to receive
Based on Article 244 quarter B of the French Fiscal code, French Partners can benefit from a tax credit of 30% of the cost for R&D services. The tax credit covers costs including salaries, social security contributions, amortization and depreciation allowances, operating costs, subcontracting, patents and monitoring. For further details on the CIR tax credit, click here.
Dr Neil Butt, IONTAS Chief Business Officer, commented “We are delighted to be able to provide our Partners access to this tax break from the French Government. This approval will facilitate access to our
About IONTAS www.iontas.co.uk
IONTAS is a biotechnology company focused on antibody discovery and cutting-edge technology development. IONTAS offers services for antibody discovery using Phage Display Technology; and the supply of bespoke phage display libraries. In addition, IONTAS offers proprietary antibody discovery platforms including Mammalian Display where
Dr Neil Butt will be attending PEGS Boston from the 8th to 12th April and will be happy to meet with you whilst at the meeting. To arrange a meeting contact firstname.lastname@example.org